Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Timolol ophthalmic - Betaliq

Next Previous
Drug Profile

Timolol ophthalmic - Betaliq

Alternative Names: BTQ-1902

Latest Information Update: 10 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Betaliq
  • Class Amino alcohols; Antiglaucomas; Antihypertensives; Ischaemic heart disorder therapies; Morpholines; Propanolamines; Small molecules; Thiadiazoles
  • Mechanism of Action Beta adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Ocular hypertension; Open-angle glaucoma

Most Recent Events

  • 10 Jul 2024 Novaliq intends to file an NDA with the US FDA for Dry eyes (Novaliq pipeline, July 2024)
  • 10 Jul 2024 The US FDA confirms with written correspondence the requirements for NDA filing (Novaliq pipeline, July 2024)
  • 10 Jul 2024 Efficacy and adverse events data from the phase II trial in Open angle glaucoma and Ocular hypertension released by Novaliq (Novaliq website, July 2024).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top